 |
Agrastim Study: Broiler Chickens On August 7, 2007, BIOAGRA, LLC announced the completion of a successful study conducted at the University of Georgia, Athens, GA, in collaboration with the Southern Poultry Research Institute under the direction of Dr. Charles Hofacre and Mr. Greg Mathis, Ph.D., President of Southern Poultry Research Institute. Dr. Hofacre is considered the foremost authority on necrotic enteritis by the poultry industry and the scientific community. The study was designed to demonstrate that Agrastim® can safely and effectively replace antibiotics in the feed of broilers when challenged by Clostridium perfringens, the agent that causes necrotic enteritis. |
 |
AgraStim Study: Dairy Cattle In an in vitro study done at the University of West Virginia, Agrastim® was mixed with rumen fluid and the disappearance of dry matter measured. Since Agrastim® was the only dry, insoluble material added, the disappearance of dry matter equals the degradation of Agrastim®. during the first 4 hours less than 15% of the Agrastim® is degraded in the rumen fluid. A small farm in West Virginia suffered a high rate of mortality of newborn calves from Cryptosporidiosis and upper respiratory infections. To determine the effect of Agrastim®on survival, 13 calves were administered 500 mg of Agrastim® in the replacement milk on the first day and 250 mg every day for the following 8 weeks. The results show that survival is greatly improved in the calves treated with Agrastim® |
 |
Agrastim®(EquiForce®)Study:Horses Agrastim® (purified Beta_1,3/1,6_D glucan) has been consistently shown to maintain the immune system in horses at peak efficiency. An efficient immune system can aid in suppressing bacterial and viral infections, can aid in maintaining a healthy status, can increase stamina and increase resistance to stress so that the horse is much more active and energetic and will show greater endurance. EquiForce® has been approved by the Florida racing commission, with reciprocal approval in other states, for use with race horses. A recent five-month study performed at the Department of Veterinary Science at Fort Valley State University, confirms the effectiveness of EquiForce® containing Agrastim®. |
 |
AgraStim Study: Turkey The purpose of the trial was to determine the effectiveness of Agrastim® in alleviating the effects of Clostridium septicum in tom turkeys. Clostridium septicum causes cellulitis or dermatitis in turkeys, a skin disease that is also referred to as necrotic dermatitis in broilers.The results of this study clearly show that Agrastim® alleviates the toxic effects of Clostridium septicum and that, given the right dose of Agrastim®, turkeys can continue to gain weight even though severely challenged. |
 |
AgraStim®: Ducks The purpose of the trial was to determine whether Agrastim® (1) affected immune parameters and (2) whether it affected growth and feed conversion performance. Ducklings were fed a feed containing Agrastim® at 45 grams/ton for 35 days. At day 35, the ducklings were processed and the following parameters measured: complement activity, anti-galactose titers (anti-gal); immunoglobulin G (IgG) and immunoglobulin M(IgM), total Immunoglobulin A (IgA), weight gain, feed conversion and mortality. |
AgriStim: Feed Conversion & Cost Savings for Producers The addition of AGRASTIM® to poultry feed has been shown to improve feed conversion, allowing the producer to bring the bird to market weight in less time, and with a lower feed cost. In trials done with broilers, feed costs to bring the bird to market weight were reduced by an average of 2 cents per bird. This means that a producer that processes 181,000,000 pounds of chicken per week could potentially realize an average net feed conversion savings of as much as $1,054,186 per week, or approximately $54,818,000 in savings per year using AGRASTIM® |
|